Literature DB >> 15718460

Editing at the crossroad of innate and adaptive immunity.

Priscilla Turelli1, Didier Trono.   

Abstract

Genetic information can be altered through the enzymatic modification of nucleotide sequences. This process, known as editing, was originally identified in the mitochondrial RNA of trypanosomes and later found to condition events as diverse as neurotransmission and lipid metabolism in mammals. Recent evidence reveals that editing enzymes may fulfill one of their most essential roles in the defense against infectious agents: first, as the mediators of antibody diversification, a step crucial for building adaptive immunity, and second, as potent intracellular poisons for the replication of viruses. Exciting questions are raised, which take us to the depth of the intimate relations between vertebrates and the microbial underworld.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718460     DOI: 10.1126/science.1105964

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  36 in total

Review 1.  DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation.

Authors:  Zhenming Xu; Zsolt Fulop; Yuan Zhong; Albert J Evinger; Hong Zan; Paolo Casali
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 2.  Lentiviral Vif: viral hijacker of the ubiquitin-proteasome system.

Authors:  Elana S Ehrlich; Xiao-Fang Yu
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

3.  Restriction of foamy viruses by APOBEC cytidine deaminases.

Authors:  Frédéric Delebecque; Rodolphe Suspène; Sara Calattini; Nicoletta Casartelli; Ali Saïb; Alain Froment; Simon Wain-Hobson; Antoine Gessain; Jean-Pierre Vartanian; Olivier Schwartz
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 4.  Cellular restriction factors affecting the early stages of HIV replication.

Authors:  Omar Perez; Thomas J Hope
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

5.  Footprint of APOBEC3 on the genome of human retroelements.

Authors:  Firoz Anwar; Miles P Davenport; Diako Ebrahimi
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

6.  Small-molecule inhibition of HIV-1 Vif.

Authors:  Robin Nathans; Hong Cao; Natalia Sharova; Akbar Ali; Mark Sharkey; Ruzena Stranska; Mario Stevenson; Tariq M Rana
Journal:  Nat Biotechnol       Date:  2008-09-21       Impact factor: 54.908

Review 7.  RNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases.

Authors:  Karen C M Moraes
Journal:  Mol Med       Date:  2009-10-07       Impact factor: 6.354

8.  Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.

Authors:  Lindi Tan; Phuong Thi Nguyen Sarkis; Tao Wang; Chunjuan Tian; Xiao-Fang Yu
Journal:  FASEB J       Date:  2008-09-30       Impact factor: 5.191

9.  Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV.

Authors:  Kristin Stieler; Nicole Fischer
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

10.  A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Authors:  Anjie Zhen; Tao Wang; Ke Zhao; Yong Xiong; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.